July 23, 2025

Stratified Antibiotic Approach Urged for cUTIs

A new guideline outlines stratified antibiotic treatment for complicated urinary tract infections, including shorter durations, oral transition timing, and tailored empiric choices based on illness severity and resistance risks.

Conexiant

July 23, 2025

Rethinking Uveitis

How might uveitis treatment be reconsidered in light of new evidence?

The Ophthalmologist

July 21, 2025

Resistance to Bedaquiline Impacts TB Survival

A cohort study found that patients with bedaquiline-resistant tuberculosis had delayed microbiologic recovery, higher rates of treatment failure, and reduced tuberculosis-free survival at 18 months compared with those with bedaquiline-susceptible disease.

Conexiant

July 21, 2025

Stanford Physician-Scientist Takes CDER Helm

Stanford's George Tidmarsh appointed FDA's new CDER director, bringing 30+ years biotechnology experience and seven approved drugs.

Conexiant

July 21, 2025

Who Watches the Watchers?

Anonymous “academic integrity watchdogs” are mounting coordinated online attacks on scientists of all stripes – with real and lasting consequences

The Analytical Scientist

July 21, 2025

Remdesivir Not Tied to Cardiac Risk

In a meta-analysis of 4566 patients with COVID-19, researchers found no statistically significant increase in cardiac adverse events associated with remdesivir treatment and concluded that the drug does not raise heart-related safety concerns.

Conexiant

July 21, 2025

Tracking Meningitis, From Days to Years

Patients from the MeninGene study contributed serum samples over 5 years, revealing that autoimmune processes rarely drive long-term cognitive problems after bacterial meningitis.

Conexiant

July 17, 2025

FDA Approves Shingrix Prefilled Syringe Option

The FDA has approved a new prefilled syringe presentation of Shingrix to simplify herpes zoster vaccination for eligible adult patients.

Conexiant

July 17, 2025

Vapes Outperform Nicotine Replacement Therapy in Cessation Trial

Researchers found vaporized nicotine products more effective than nicotine replacement therapy for smoking cessation among socioeconomically disadvantaged adults.

Conexiant